// App-Quantinova.ai

: Persistence with Insulin Glargine 300 IU/ml Compared with Other Basal Insulins—A Canadian Retrospective Cohort Study

Researchers

Presenter

  • KOBINA A. QUANSAH

Principal Investigators

  • LUC SAURIOL

  • ATIF A. KUKASWADIA

  • SAMANTHA BREMNER

Medical Centers

  • N/A

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • Insulin

Drug/Treatment

  • Insulin glargine

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved